These data are consistent with the hypothesis that inhibition of the TGF-β signaling pathway enhances the efficacy of chemotherapeutic drugs, suggesting that the combined use of 5FU and SB431542 could be an interesting new approach to the treatment of GC. The gene discussed is TGFB1; the disease is gastric cancer.